16-67431300-C-T

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4

The NM_000196.4(HSD11B2):​c.52C>T​(p.Arg18Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000166 in 1,264,368 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00011 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0000036 ( 0 hom. )

Consequence

HSD11B2
NM_000196.4 missense

Scores

3
5
11

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.0370
Variant links:
Genes affected
HSD11B2 (HGNC:5209): (hydroxysteroid 11-beta dehydrogenase 2) There are at least two isozymes of the corticosteroid 11-beta-dehydrogenase, a microsomal enzyme complex responsible for the interconversion of cortisol and cortisone. The type I isozyme has both 11-beta-dehydrogenase (cortisol to cortisone) and 11-oxoreductase (cortisone to cortisol) activities. The type II isozyme, encoded by this gene, has only 11-beta-dehydrogenase activity. In aldosterone-selective epithelial tissues such as the kidney, the type II isozyme catalyzes the glucocorticoid cortisol to the inactive metabolite cortisone, thus preventing illicit activation of the mineralocorticoid receptor. In tissues that do not express the mineralocorticoid receptor, such as the placenta and testis, it protects cells from the growth-inhibiting and/or pro-apoptotic effects of cortisol, particularly during embryonic development. Mutations in this gene cause the syndrome of apparent mineralocorticoid excess and hypertension. [provided by RefSeq, Feb 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.3406995).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
HSD11B2NM_000196.4 linkc.52C>T p.Arg18Cys missense_variant 1/5 ENST00000326152.6 NP_000187.3 P80365
HSD11B2XM_047434048.1 linkc.-48+521C>T intron_variant XP_047290004.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
HSD11B2ENST00000326152.6 linkc.52C>T p.Arg18Cys missense_variant 1/51 NM_000196.4 ENSP00000316786.5 P80365
ENSG00000261320ENST00000567261.1 linkn.135+30G>A intron_variant 3
HSD11B2ENST00000567684.2 linkn.128+521C>T intron_variant 3
HSD11B2ENST00000569303.1 linkn.27+152C>T intron_variant 5

Frequencies

GnomAD3 genomes
AF:
0.000113
AC:
17
AN:
150310
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000243
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000397
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000484
GnomAD4 exome
AF:
0.00000359
AC:
4
AN:
1113950
Hom.:
0
Cov.:
30
AF XY:
0.00000185
AC XY:
1
AN XY:
541626
show subpopulations
Gnomad4 AFR exome
AF:
0.0000444
Gnomad4 AMR exome
AF:
0.0000551
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000469
GnomAD4 genome
AF:
0.000113
AC:
17
AN:
150418
Hom.:
0
Cov.:
31
AF XY:
0.000123
AC XY:
9
AN XY:
73438
show subpopulations
Gnomad4 AFR
AF:
0.000242
Gnomad4 AMR
AF:
0.000397
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.000479
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.000174

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 19, 2024The c.52C>T (p.R18C) alteration is located in exon 1 (coding exon 1) of the HSD11B2 gene. This alteration results from a C to T substitution at nucleotide position 52, causing the arginine (R) at amino acid position 18 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.72
BayesDel_addAF
Uncertain
0.085
D
BayesDel_noAF
Benign
-0.11
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.28
T
Eigen
Benign
0.17
Eigen_PC
Benign
0.18
FATHMM_MKL
Benign
0.39
N
LIST_S2
Benign
0.75
T
M_CAP
Pathogenic
0.99
D
MetaRNN
Benign
0.34
T
MetaSVM
Uncertain
-0.25
T
MutationAssessor
Benign
0.0
N
PrimateAI
Pathogenic
0.96
D
PROVEAN
Benign
-0.16
N
REVEL
Uncertain
0.51
Sift
Benign
0.098
T
Sift4G
Uncertain
0.055
T
Polyphen
1.0
D
Vest4
0.32
MutPred
0.50
Loss of MoRF binding (P = 2e-04);
MVP
0.92
MPC
1.7
ClinPred
0.65
D
GERP RS
3.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.6
Varity_R
0.15
gMVP
0.62

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs556122396; hg19: chr16-67465203; API